Search results
Moderna says FDA delaying decision on RSV vaccine approval
Stars and Stripes· 5 days agoUS regulators’ decision on whether to approve Moderna Inc.’s vaccine for RSV has been delayed due to...
What's Going With Moderna Stock On Friday? - Moderna (NASDAQ:MRNA)
Benzinga· 5 days agoThe agency, citing administrative constraints, does not expect to complete its review of the Biologics License Application (BLA) for mRNA-1345, Moderna’s investigational respiratory ...
Was COVID vaccine recalled over health danger fears? What we know
Newsweek· 6 days agoPharmaceutical company AstraZeneca has initiated a global withdrawal of its COVID-19 vaccine just...
Moderna’s mRNA dreams meet reality with first post-COVID shot - The Boston Globe
The Boston Globe· 6 days agoModerna’s stock dropped 45 percent last year, making it the worst-performing large biotech in the...
If You'd Invested $1,000 in Moderna Stock 5 Years Ago, Here's How Much You'd Have Today
Motley Fool via Yahoo Finance· 6 days agoOther nations' regulatory bodies followed suit. The rest, as they say, is history. Pandemic-prompted...
The AstraZeneca vaccine – should you be worried?
The Telegraph via Yahoo News· 4 days agoEarlier this week, the European Commission announced that the Covid-19 vaccine, developed as part of a collaboration between the British pharma company...
Is Moderna Inc (MRNA) Set to Underperform? Analyzing the Factors
Guru Focus· 1 day agoLong-established in the Biotechnology industry, Moderna Inc (MRNA, Financial) has enjoyed a stellar reputation. Notably, its diminished rankings in financial strength, growth ...
Bull Market and Beyond: 2 Stocks Just Waiting to Soar | The Motley Fool
The Motley Fool· 2 days agoLet's consider two such stocks: Moderna (MRNA 7.13%) and DexCom (DXCM -1.65%). Moderna is one of the...
Novavax, Nvidia, Sweetgreen rise premarket; Moderna, Yelp fall By Investing.com
Investing.com· 5 days agoNovavax, Nvidia, Sweetgreen rise premarket; Moderna, Yelp fall
Bull Market and Beyond: 2 Stocks Just Waiting to Soar
Motley Fool via Yahoo Finance· 2 days agoFortunately, there are good reasons to believe the company has what it takes. Moderna is inching...